Clinical Research Directory
Browse clinical research sites, groups, and studies.
Determination of Molecular Status, the Efficacy and Safety of Fluorodeoxyglucose in PET-CT Imaging
Sponsor: Anna Raciborska
Summary
Prospective, low intervention, open, single-center, non-commercial clinical trial to improve diagnostics in patients with histiocytosis by assessing the molecular profile of the tumor tissues, monitoring its presence in free-circulating DNA, and determining the efficacy of fluorodeoxyglucose (18F-FDG) in PET-CT imaging.
Official title: Determination of Molecular Status, as Well as the Efficacy and Safety of Fluorodeoxyglucose (18F-FDG) in PET-CT Imaging in Juvenile Patients With Histiocytosis
Key Details
Gender
All
Age Range
1 Year - 18 Years
Study Type
INTERVENTIONAL
Enrollment
150
Start Date
2021-04-01
Completion Date
2027-06-30
Last Updated
2026-03-25
Healthy Volunteers
No
Conditions
Interventions
fluorodeoxyglucose (18F-FDG)
max 6 MGBq/kg, no more than 100
Locations (1)
Mother and Child Institute
Warsaw, Mazovian, Poland